Article ID Journal Published Year Pages File Type
2578615 Thérapie 2016 8 Pages PDF
Abstract
Pharmacovigilance aims to identify unknown adverse drug reactions once clinical development is complete, in order to promote improved use of drugs, and thus a reduction in risk for every exposed patient. We describe in this article the missions of French pharmacovigilance system, including French drug agency, Regional Centers of Pharmacovigilance, health professionals, pharmaceutical companies, patients and their associations. We also develop the French pharmacovigilance organization, its perspectives and challenges, both in French and European levels.
Related Topics
Health Sciences Pharmacology, Toxicology and Pharmaceutical Science Pharmacology, Toxicology and Pharmaceutics (General)
Authors
,